Serotonin transporter protein polymorphism and harm avoidance personality in migraine without aura

Headache

Volumn 46, Issue 6, 2006, Pages 991-996

  Jeong, Wook Park ^a   Si, Ryung Han ^a   Dong, Won Yang ^a   Yeong, In Kim ^a   Kwang, Soo Lee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Harm avoidance; Migraine without aura; Polymorphism; Serotonin transporter protein

Indexed keywords

NEUROTRANSMITTER; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; ALLELE; ARTICLE; AVOIDANT PERSONALITY DISORDER; CONTROLLED STUDY; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MIGRAINE WITHOUT AURA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; QUESTIONNAIRE; SEROTONINERGIC SYSTEM; SYNAPTIC TRANSMISSION; TANDEM REPEAT;

ADULT; GENE FREQUENCY; GENOTYPE; HARM REDUCTION; HUMANS; INTRONS; MIDDLE AGED; MIGRAINE WITHOUT AURA; PERSONALITY; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TANDEM REPEAT SEQUENCES;

EID: 33646930308     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00439.x     Document Type: Article

References (39)

1. Tfelt-Hansen P. Sumatriptan for the treatment of migraine attacks - a review of controlled clinical trials. Cephalalgia. 1993 13:238 244.
2. Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology. 1989 39:1239 1242.
3. Fozard JR. Serotonin, migraine and platelets. Prog Pharmacol. 1982 4:135 146.
4. Humphrey PP. 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol. 1991 238 suppl 1 S38 S44.
5. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 1:658 660.
6. Honkasalo ML, Kaprio J, Winter T, Heikkila K, Sillanpaa M, Koskenvuo M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache. 1995 35:70 78.
7. Larsson B, Bille B, Pedersen NL. Genetic influence in headaches: A Swedish twin study. Headache. 1995 35:513 519.
8. Russell MB, Olesen J. The genetics of migraine without aura and migraine with aura. Cephalalgia. 1993 13:245 248.
9. Ogilvie AD, Russell MB, Dhall P, et al. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia. 1998 18:23 26.
10. Kotani K, Shimomura T, Shimomura F, Ikawa S, Nanba E. A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache. 2002 42:893 895.
11. Erdal ME, Herken H, Yilmaz M, Bayazit YA. Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J Neurol Sci. 2001 188:99 101.
12. Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA. Significance of serotonin transporter gene polymorphism in migraine. Neurol Sci. 2001 186:27 30.
13. Lesch KP, Balling U, Gross J, et al. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect. 1994 95:157 162.
14. Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A. 1993 90:2542 2546.
15. Heils A, Teufel A, Petri S, et al. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm Gen Sect. 1995 102:247 254.
16. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996 66:2621 2624.
17. Kaiser R, Muller-Oerlinghausen B, Filler D, et al. Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter. Am J Med Genet. 2002 114:323 328.
18. MacKenzie A, Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A. 1999 96:15251 15215.
19. Kim DK, Lim SW, Lee S, et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport. 2000 11:215 219.
20. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996 274:1527 1531.
21. Park JW, Kim JS, Lee HK, Kim YI, Lee KS. Serotonin transporter polymorphism and harm avoidance personality in chronic tension-type headache. Headache. 2004 44:1005 1009.
22. Park JW, Kim JS, Kim YI, Lee KS. Serotonergic activity contributes to analgesic overuse in chronic tension-type headache. Headache. 2005 45:1229 1235.
23. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986 4:167 226.
24. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987 44:573 588.
25. Hansenne M, Ansseau M. Harm avoidance and serotonin. Biol Psychol. 1999 51:77 81.
26. Hansenne M, Pitchot W, Moreno AG, Reggers J, Machurot PY, Ansseau M. Harm avoidance dimension of the tridimensional personality questionnaire and serotonin-1A activity in depressed patients. Biol Psychiatry. 1997 42:959 961.
27. Thierry N, Willeit M, Praschak-Rieder N, Zill P, Hornik K. Serotonin transporter promoter gene polymorphic region (5-HTTLPR) and personality in female patients with seasonal affective disorder and in healthy controls. Eur Neuropsychopharmacol. 2004 14:53 58.
28. Headache classification subcommittee of the international headache society. The international classification of headache disorders. 2nd edition. Cephalagia. 2004 24 suppl 1 160.
29. Ogilvie AD, Battersby S, Bubb VJ. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 1996 16:731 733.
30. Ebstein RP, Novick O, Umansky R, et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet. 1996 12:78 80.
31. Curtin F, Walker JP, Peyrin L, Soulier V, Badan M, Schulz P. Reward dependence is positively related to urinary monoamines in normal men. Biol Psychiatry. 1997 42:275 281.
32. Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: A systematic review. Mol Psychiatry. 2004 9:433 441.
33. Kent L, Doerry U, Hardy E, et al. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): Analysis and pooled analysis. Mol Psychiatry. 2002 7:908 912.
34. Ito K, Yoshida K, Sato K, et al. A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine. Psychiatry Res. 2002 111:235 239.
35. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995 311:541 544.
36. Heath AC, Cloninger CR, Martin NG. Testing a model for the genetic structure of personality: A comparison of the personality systems of Cloninger and Eysenck. J Pers Soc Psychol. 1994 66:762 775.
37. Stallings MC, Hewitt JK, Cloninger CR, Heath AC, Eaves LJ. Genetic and environmental structure of the tridimensional personality questionnaire: Three or four temperament dimensions¿ J Pers Soc Psychol. 1996 70:127 140.
38. Pud D, Eisenberg E, Sprecher E, Rogowski Z, Yarnitsky D. The tridimensional personality theory and pain: Harm avoidance and reward dependence traits correlate with pain perception in healthy volunteers. Eur J Pain. 2004 8:31 38.
39. Ricketts MH, Hamer RM, Sage JI, Manowitz P, Feng F, Menza MA. Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population. Psychiatr Gene. 1998 8:41 44.